NCT03946865

Brief Summary

Researchers are trying to determine if offering and providing reiki therapy in hospitalized hematology/oncology cancer subjects has any effects on symptoms and feeling during the subjects hospital stay.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2019

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 9, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 13, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

July 10, 2019

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
Last Updated

May 3, 2021

Status Verified

April 1, 2021

Enrollment Period

1.7 years

First QC Date

May 9, 2019

Last Update Submit

April 28, 2021

Conditions

Outcome Measures

Primary Outcomes (7)

  • Change in pain pain symptoms

    Measured using a numeric rating scale, where 0 is not at all and 10 is unbearable

    Baseline, approximately 2 hours

  • Change in fatigue symptoms

    Measured using a numeric rating scale, where 0 is not at all and 10 is unbearable

    Baseline, approximately 2 hours

  • Change in anxiety symptoms

    Measured using a numeric rating scale, where 0 is not at all and 10 is unbearable

    Baseline, approximately 2 hours

  • Change in feeling happy

    Measured using a numeric rating scale, where 0 is best possible and 10 is worst possible

    Baseline, approximately 2 hours

  • Change in feeling energized

    Measured using a numeric rating scale, where 0 is best possible and 10 is worst possible

    Baseline, approximately 2 hours

  • Change in feeling relaxed

    Measured using a numeric rating scale, where 0 is best possible and 10 is worst possible

    Baseline, approximately 2 hours

  • Change in feeling calm

    Measured using a numeric rating scale, where 0 is best possible and 10 is worst possible

    Baseline, approximately 2 hours

Study Arms (1)

Hospitalized hematology/oncology cancer subjects

EXPERIMENTAL

Hospitalized hematology/oncology cancer will participate in Reiki Therapy

Other: Reiki Therapy

Interventions

Reiki is a healing practice that originated in Japan. Reiki practitioners place their hands lightly on or just above the person receiving treatment, with the goal of facilitating the person's own healing response.

Hospitalized hematology/oncology cancer subjects

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hospitalized hematology-oncology patients age 18 - 80
  • Able to speak English and complete surveys
  • Able to read, understand and sign inform consent.

You may not qualify if:

  • Patient unwilling for reiki therapy.
  • Unable to give written consent.
  • Already having received or receiving other reiki treatment.
  • Pregnant women. (As verbalized by participant)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

Related Links

MeSH Terms

Conditions

Neoplasms

Interventions

Therapeutic Touch

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual Therapies

Study Officials

  • Brent Bauer, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 9, 2019

First Posted

May 13, 2019

Study Start

July 10, 2019

Primary Completion

April 1, 2021

Study Completion

April 1, 2021

Last Updated

May 3, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations